Abdominal Abscess: Clinical Trials

10 trials for Abdominal Abscess, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 terminated, 2 unknown. 10 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 310Completed 3, Recruiting 2, Terminated 2, Unknown 2, Not yet recruiting 1

Follow Abdominal Abscess: new trials by email Literature Review of Abdominal Abscess trials Research Report on Abdominal Abscess

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Diloxanide Furoate as Additional Luminal Agent Along With Metronidazole for the Treatment of Amoebic Liver Abscess
Diloxanide furoate, Placebo - Liver Abscess, Amoebic Liver Abscess
Phase 3Not yet recruitingPost Graduate Institute of Medical Education and Research, Chandigarh2202026-09-042026-09-10
Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess
Intravenous beta-lactam antimicrobial for 2 weeks Plus Intravenous Metronidazole (750 mg q 8 hourly) for 2 weeks, Tablet Cefixime (200 mg q 12 hourly) for 2 weeks Plus Tablet Metronidazole (800 mg q 8 hourly) for 2 weeks, Standard medical care - Liver Abscess
Phase 3RecruitingPost Graduate Institute of Medical Education and Research, Chandigarh2202025-02-252025-04-13
Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis
Laparoscopic antibiotic peritoneal lavage with gentamicin / clindamycin - Complicated Appendicitis, Intra-Abdominal Abscess
Phase 3RecruitingSpaarne Gasthuis7522025-02-242026-10-09
Ciprofloxacin Plus Metronidazole Vs Cefixime Plus Metronidazole Therapy for the Treatment of Liver Abscess
Ciprofloxacin, Cefixime - Liver Abscess
Phase 3UnknownPost Graduate Institute of Medical Education and Research, Chandigarh1402019-07-012019-07-22
Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study
Cathflo (Alteplase), Saline - Intra-abdominal Abscess
Phase 3TerminatedThe Hospital for Sick Children282012-03-012019-06-27
Microbiological Spectrum of the Intraperitoneal Surface After Elective Right-sided Colon Cancer
Stapled anastomosis, Handsewn anastomosis - Peritoneal Contamination After Ileocolonic Anastomosis, Wound Infection
Phase 3UnknownHospital General Universitario Elche802011-11-012011-10-24
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Doripenem, Meropenem placebo, Meropenem - Abscess, Intra-Abdominal, Abdominal Abscess
Phase 3TerminatedJanssen Research & Development, LLC412010-12-012014-07-15
Effect of Peritoneal Lavage With Clindamycin-gentamicin Solution on Postoperative Colorectal Cancer Infection in Elective Surgery
Intra-peritoneal antibiotic lavage - Surgical Site Infection
Phase 3CompletedUniversidad Miguel Hernandez de Elche1022010-01-012011-06-22
Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses
Moxifloxacin/Metronidazole or Piperacillin/Tazobactam - Abscess, Intra-Abdominal
Phase 3CompletedHannover Medical School1802005-11-152018-07-24
Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections
tigecycline - Abdominal Abscess
Phase 3CompletedWyeth is now a wholly owned subsidiary of Pfizer2002005-11-012009-07-07

Narrower conditions

Liver Abscess (3)  ·  Abscess (2)  ·  Peritonitis (2)  ·  Wound Infection (2)  ·  Abdomen, Acute (1)  ·  Abdominal Pain (1)  ·  Appendicitis (1)  ·  Community-Acquired Infections (1)  ·  Cross Infection (1)  ·  Ileus (1)  ·  Infections (1)  ·  Intestinal Perforation (1)  ·  Liver Abscess, Amebic (1)  ·  Rupture (1)

Broader conditions

Suppuration (10)  ·  Infections (9)  ·  Abscess (8)  ·  Digestive System Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pathologic Processes (4)  ·  Liver Diseases (3)  ·  Inflammation (2)  ·  Intraabdominal Infections (2)  ·  Peritoneal Diseases (2)  ·  Amebiasis (1)  ·  Cecal Diseases (1)  ·  Disease Attributes (1)  ·  Gastroenteritis (1)

Interventions

Metronidazole (2)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Cefixime (1)  ·  Ciprofloxacin (1)  ·  Clindamycin (1)  ·  Doripenem (1)  ·  Gentamicins (1)  ·  Meropenem (1)  ·  Moxifloxacin (1)  ·  Piperacillin, Tazobactam Drug Combination (1)  ·  Sodium Chloride (1)  ·  Standard of Care (1)  ·  Tigecycline (1)  ·  Tissue Plasminogen Activator (1)  ·  WW Domain-Containing Oxidoreductase (1)

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh (3)  ·  Hannover Medical School (1)  ·  Hospital General Universitario Elche (1)  ·  Janssen Research & Development, LLC (1)  ·  Spaarne Gasthuis (1)  ·  The Hospital for Sick Children (1)  ·  Universidad Miguel Hernandez de Elche (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

India (3)  ·  Argentina (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Colombia (1)  ·  Germany (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  Panama (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Antonio Arroyo, MD, PhD (1)  ·  Bairbre Connolly, MD (1)  ·  Deba P Dhibar, MD (1)  ·  Jaime Ruiz-Tovar, MD, PhD (1)  ·  Michael Winkler, Prof (1)

Results publications

PMID 19036670, PMID 20663130, PMID 22265220, PMID 22581209, PMID 38769330

NIH funding

2009 (1)